PASITHEA THERAPEUTICS CORP.
PASITHEA THERAPEUTICS CORP. is a registered legal entity registered in United States under F21000002789, and its current status with Florida Department of State — Sunbiz is active. The company was incorporated on 19 May 2021 and lists its registered address as MIAMI BEACH, United States. 5 shareholders are on record for PASITHEA THERAPEUTICS CORP., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Florida Department of State — Sunbiz and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for PASITHEA THERAPEUTICS CORP., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Kepos Capital Lp, holding 25.8% — the largest recorded stake — followed by Citadel Advisors Llc at 5.2%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 15 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Kepos Capital Lp | 25.8% | Florida Department of State — Sunbiz | |
| Citadel Advisors Llc | 5.2% | Florida Department of State — Sunbiz | |
| Vanguard Group Inc | 4.2% | Florida Department of State — Sunbiz | |
| Armistice Capital, LLC | 3.9% | Florida Department of State — Sunbiz | |
| Two Sigma Investments, LP | 2.8% | Florida Department of State — Sunbiz |
Officers
5
The Co-founder, Md & Executive Chairman of PASITHEA THERAPEUTICS CORP. currently on record is Lawrence Steinman Ba, M.d., Ph.d.; five officers are currently on record for PASITHEA THERAPEUTICS CORP., filed with Florida Department of State — Sunbiz.
Management authority at PASITHEA THERAPEUTICS CORP. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns PASITHEA THERAPEUTICS CORP.?
Five shareholders are currently on record for PASITHEA THERAPEUTICS CORP., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Kepos Capital Lp, holding 25.8% — the largest recorded stake — followed by Citadel Advisors Llc at 5.2%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is PASITHEA THERAPEUTICS CORP.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for PASITHEA THERAPEUTICS CORP. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does PASITHEA THERAPEUTICS CORP. have on record?
5 shareholders are shown on record for PASITHEA THERAPEUTICS CORP.. The register reports 15 in total; only the top 5 by holding are shown here.
What is PASITHEA THERAPEUTICS CORP.'s company registration number?
PASITHEA THERAPEUTICS CORP.'s registration number is F21000002789, filed with Florida Department of State — Sunbiz in United States. Its current status on the register is active.
Is PASITHEA THERAPEUTICS CORP. still an active company?
PASITHEA THERAPEUTICS CORP.'s status on Florida Department of State — Sunbiz is listed as active.
When was PASITHEA THERAPEUTICS CORP. incorporated?
PASITHEA THERAPEUTICS CORP. was incorporated on 19 May 2021, according to Florida Department of State — Sunbiz.
What is PASITHEA THERAPEUTICS CORP.'s registered address?
The registered address on file for PASITHEA THERAPEUTICS CORP. is MIAMI BEACH, United States.
Who are the officers/directors of PASITHEA THERAPEUTICS CORP.?
The Co-founder, Md & Executive Chairman of PASITHEA THERAPEUTICS CORP. currently on record is Lawrence Steinman Ba, M.d., Ph.d.; five officers are currently on record for PASITHEA THERAPEUTICS CORP., filed with Florida Department of State — Sunbiz. Management authority at PASITHEA THERAPEUTICS CORP. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to PASITHEA THERAPEUTICS CORP.'s ownership over time?
This profile reflects a point-in-time snapshot from Florida Department of State — Sunbiz. Zavia's monitoring API can track changes to PASITHEA THERAPEUTICS CORP.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access PASITHEA THERAPEUTICS CORP.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like PASITHEA THERAPEUTICS CORP.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Florida Department of State — Sunbiz and was last synced on 21 October 2026.